@LAzzaliniMD ABSOLUTELY.
Mongo and everyone else can share "off label" usage historically. No PTCA balloon in the Primary PTCA era was ever approved and indicated in STEMI PCI.
The administrators and attorneys do pay attention to the labels. Many ICs are in different states & situations
Elderly gentleman with resuscitated VF arrest.
Baseline angio followed by angio and IVUS (MSA) after IVL+scoring+cutting balloon of the diagonal.
How would you finalize treatment?
Stent? DEB/DCB? Hybrid stent+DEB/DCB?
Our article reviewing radial access procedures in patients with Raynauds phenomenon published today - this is an important issue for all operators
Thanks to first author Dr Shamkhani and to our multidisciplinary coauthors
https://t.co/HLjPPPJyeB
True that. As far as I know eccentricity doesn’t matter when you hit your MSA’s target. Question is: does the additional gain of 1-2 mm2 when you already crossed 5.8 mm2, justify an additional cost of 2.k to 3k per case? Rota/csi I think have a role when you can’t get any equipment to cross and often these cases justly need both ( our internal data consistent with the trial findings). I agree with you jack( as always lol) that there might be a failure mode related to the nodule modification itself that can drive future events.
@AntoniousAttall@GilbertTangMD@DoctorKini@JACCJournals@crfheart@TCTMD This is an important paper. It is what we have seen anecdotally and now have some data. Congrats to the authors.
Will it be shown to lead to clinical effect? I think so and it will be interesting to see.
LOL, remember when we didn't even know about nodules because we didn't look
In the NODULE-SHOCK trial, researchers evaluated phenotype-specific calcium modification in patients with and without severely calcified nodules using a new-generation coronary IVL catheter.
🔎 Explore the trial findings: https://t.co/C3ABVcsZ5G
#TCT2026#JACCINT@crfheart